← All Sponsors
SPONSOR

Nykode Therapeutics ASA

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: HPV Positive Oropharyngeal Squamous Cell CarcinomaHNSCC
NCT06016920 Phase 1, Phase 2
Recruiting

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

HPV Positive Oropharyngeal Squamous Cell Carcinoma
Czechia, France, Germany View Trial →